Are structural characteristics of programs and hospitals associated with 100-day readmission of hematopoietic SCTs in Taiwan

S. I. Hsieh, M. Johantgen, L. L. Hsu, M. C. Kuo, Tsung-Hsueh Lu

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Hematopoietic SCT (HSCT) is one treatment modality for hematological malignancies. It is increasingly common but remains centralized in certain hospitals wherein procedures and protocols can vary. This study examined 100-day readmission for patients with hematological malignancies undergoing HSCT in Taiwan from the years 2001 to 2006. Of particular interest was an examination of how HSCT program characteristics might influence outcomes. This population-based retrospective cohort study with longitudinal follow-up used Taiwan's National Health Insurance Research Database. A generalized linear model with a logistic-dependent variable representing being admitted or not admitted was used to model 100-day readmission, adjusting for the nested design. There were 718 HSCT recipients for hematological malignancies in the 5-year study period from 10 HSCT programs. In spite of the average length of stay of 43.71 days (s.d.25.75) days, 52% of recipients were readmitted within 100 days of discharge. Ownership status, the number of HSCT hematologists, and the ratio of HSCT procedures to HSCT hematologists independently predicted 100-day readmission after adjusting for clustered data and controlling for recipient characteristics.

Original languageEnglish
Pages (from-to)1203-1209
Number of pages7
JournalBone Marrow Transplantation
Volume46
Issue number9
DOIs
Publication statusPublished - 2011 Sep 1

Fingerprint

Hematologic Neoplasms
Taiwan
Patient Readmission
Ownership
National Health Programs
Linear Models
Length of Stay
Cohort Studies
Retrospective Studies
Databases
Research
Population
Therapeutics

All Science Journal Classification (ASJC) codes

  • Hematology
  • Transplantation

Cite this

@article{359dc819c8d24bf0bb11f8fcc3f3505e,
title = "Are structural characteristics of programs and hospitals associated with 100-day readmission of hematopoietic SCTs in Taiwan",
abstract = "Hematopoietic SCT (HSCT) is one treatment modality for hematological malignancies. It is increasingly common but remains centralized in certain hospitals wherein procedures and protocols can vary. This study examined 100-day readmission for patients with hematological malignancies undergoing HSCT in Taiwan from the years 2001 to 2006. Of particular interest was an examination of how HSCT program characteristics might influence outcomes. This population-based retrospective cohort study with longitudinal follow-up used Taiwan's National Health Insurance Research Database. A generalized linear model with a logistic-dependent variable representing being admitted or not admitted was used to model 100-day readmission, adjusting for the nested design. There were 718 HSCT recipients for hematological malignancies in the 5-year study period from 10 HSCT programs. In spite of the average length of stay of 43.71 days (s.d.25.75) days, 52{\%} of recipients were readmitted within 100 days of discharge. Ownership status, the number of HSCT hematologists, and the ratio of HSCT procedures to HSCT hematologists independently predicted 100-day readmission after adjusting for clustered data and controlling for recipient characteristics.",
author = "Hsieh, {S. I.} and M. Johantgen and Hsu, {L. L.} and Kuo, {M. C.} and Tsung-Hsueh Lu",
year = "2011",
month = "9",
day = "1",
doi = "10.1038/bmt.2010.282",
language = "English",
volume = "46",
pages = "1203--1209",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "9",

}

Are structural characteristics of programs and hospitals associated with 100-day readmission of hematopoietic SCTs in Taiwan. / Hsieh, S. I.; Johantgen, M.; Hsu, L. L.; Kuo, M. C.; Lu, Tsung-Hsueh.

In: Bone Marrow Transplantation, Vol. 46, No. 9, 01.09.2011, p. 1203-1209.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Are structural characteristics of programs and hospitals associated with 100-day readmission of hematopoietic SCTs in Taiwan

AU - Hsieh, S. I.

AU - Johantgen, M.

AU - Hsu, L. L.

AU - Kuo, M. C.

AU - Lu, Tsung-Hsueh

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Hematopoietic SCT (HSCT) is one treatment modality for hematological malignancies. It is increasingly common but remains centralized in certain hospitals wherein procedures and protocols can vary. This study examined 100-day readmission for patients with hematological malignancies undergoing HSCT in Taiwan from the years 2001 to 2006. Of particular interest was an examination of how HSCT program characteristics might influence outcomes. This population-based retrospective cohort study with longitudinal follow-up used Taiwan's National Health Insurance Research Database. A generalized linear model with a logistic-dependent variable representing being admitted or not admitted was used to model 100-day readmission, adjusting for the nested design. There were 718 HSCT recipients for hematological malignancies in the 5-year study period from 10 HSCT programs. In spite of the average length of stay of 43.71 days (s.d.25.75) days, 52% of recipients were readmitted within 100 days of discharge. Ownership status, the number of HSCT hematologists, and the ratio of HSCT procedures to HSCT hematologists independently predicted 100-day readmission after adjusting for clustered data and controlling for recipient characteristics.

AB - Hematopoietic SCT (HSCT) is one treatment modality for hematological malignancies. It is increasingly common but remains centralized in certain hospitals wherein procedures and protocols can vary. This study examined 100-day readmission for patients with hematological malignancies undergoing HSCT in Taiwan from the years 2001 to 2006. Of particular interest was an examination of how HSCT program characteristics might influence outcomes. This population-based retrospective cohort study with longitudinal follow-up used Taiwan's National Health Insurance Research Database. A generalized linear model with a logistic-dependent variable representing being admitted or not admitted was used to model 100-day readmission, adjusting for the nested design. There were 718 HSCT recipients for hematological malignancies in the 5-year study period from 10 HSCT programs. In spite of the average length of stay of 43.71 days (s.d.25.75) days, 52% of recipients were readmitted within 100 days of discharge. Ownership status, the number of HSCT hematologists, and the ratio of HSCT procedures to HSCT hematologists independently predicted 100-day readmission after adjusting for clustered data and controlling for recipient characteristics.

UR - http://www.scopus.com/inward/record.url?scp=80052512289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052512289&partnerID=8YFLogxK

U2 - 10.1038/bmt.2010.282

DO - 10.1038/bmt.2010.282

M3 - Article

VL - 46

SP - 1203

EP - 1209

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 9

ER -